Literature DB >> 18476155

Six years observation after successful treatment of bacterial vaginosis.

J Boris1, C Påhlson, P G Larsson.   

Abstract

OBJECTIVE: The cure rate after treatment of bacterial vaginosis (BV) differs in various investigations, but most studies report a cure rate of 70% after 1 month.
METHODS: A long-term observation study after successful treatment of BV has been undertaken. The original study was a treatment study of BV and included 50 patients.
RESULTS: We were able to identify 44 of the original 50 patients. The mean follow-up time was 6.9 years (range 4.7-9 years). During this time, 21 women (48%) had been free of BV while 23 women had had relapses. There was no difference in the use of broad-spectrum antibiotics, episodes of candida vaginitis, bleeding disturbances, family planning method, development of cervical intraepithelial neoplasia (CIN), or gynecological operations between women with and without relapses. The women with relapses had had a new sexual contact more often during the observation period than women without relapses. There was no difference in hydrogen peroxide production of the lactobacilli among women with or without relapses, and survival analysis shows that most relapses occur during the first year after treatment.
CONCLUSIONS: If patients are successfully treated, half of the patients will stay cured indicating that treatment is of benefit. Most relapses occur during the first year. Our results indicate that the etiology of BV might have something to do with new sexual contacts.

Entities:  

Year:  1997        PMID: 18476155      PMCID: PMC2364553          DOI: 10.1155/S1064744997000513

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  22 in total

1.  Treatment of bacterial vaginosis.

Authors:  P G Larsson
Journal:  Int J STD AIDS       Date:  1992 Jul-Aug       Impact factor: 1.359

2.  Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis.

Authors:  D A Eschenbach; P R Davick; B L Williams; S J Klebanoff; K Young-Smith; C M Critchlow; K K Holmes
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

3.  Nonspecific vaginitis: role of Haemophilus vaginalis and treatment with metronidazole.

Authors:  T A Pheifer; P S Forsyth; M A Durfee; H M Pollock; K K Holmes
Journal:  N Engl J Med       Date:  1978-06-29       Impact factor: 91.245

4.  Enumeration of clue cells in rehydrated air-dried vaginal wet smears for the diagnosis of bacterial vaginosis.

Authors:  P G Larsson; J J Platz-Christensen
Journal:  Obstet Gynecol       Date:  1990-10       Impact factor: 7.661

5.  [Bacterial vaginosis associated with Mobiluncus species in general practice].

Authors:  O G Nygaard; P A Csángó; G Jagars
Journal:  Tidsskr Nor Laegeforen       Date:  1991-03-10

6.  Comparison of Gram-stained smears prepared from blind vaginal swabs with those obtained at speculum examination for the assessment of vaginal flora.

Authors:  D J Morgan; C J Aboud; I M McCaffrey; S A Bhide; R F Lamont; D Taylor-Robinson
Journal:  Br J Obstet Gynaecol       Date:  1996-11

7.  Treatment of bacterial vaginosis in women with vaginal bleeding complications or discharge and harboring Mobiluncus.

Authors:  P G Larsson; B Bergman; U Forsum; C Påhlson
Journal:  Gynecol Obstet Invest       Date:  1990       Impact factor: 2.031

8.  Is bacterial vaginosis a sexually transmitted disease?

Authors:  P G Larsson; J J Platz-Christensen; E Sundström
Journal:  Int J STD AIDS       Date:  1991 Sep-Oct       Impact factor: 1.359

9.  Diagnosis and clinical manifestations of bacterial vaginosis.

Authors:  D A Eschenbach; S Hillier; C Critchlow; C Stevens; T DeRouen; K K Holmes
Journal:  Am J Obstet Gynecol       Date:  1988-04       Impact factor: 8.661

10.  Prevalence of bacterial vaginosis and its association with genital infections, inflammation, and contraceptive methods in women attending sexually transmitted disease and primary health clinics.

Authors:  H Moi
Journal:  Int J STD AIDS       Date:  1990-03       Impact factor: 1.359

View more
  10 in total

1.  NATURAL ANTIMICROBIALS AND THEIR ROLE IN VAGINAL HEALTH: A SHORT REVIEW.

Authors:  S E Dover; A A Aroutcheva; S Faro; M L Chikindas
Journal:  Int J Probiotics Prebiotics       Date:  2008

2.  A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis.

Authors:  Jose A Simoes; Luis G Bahamondes; Rodrigo P S Camargo; Valeria M N Alves; Lourens J D Zaneveld; Donald P Waller; Jill Schwartz; Marianne M Callahan; Christine K Mauck
Journal:  Br J Clin Pharmacol       Date:  2006-02       Impact factor: 4.335

3.  Polyethylene glycol-based hydrogels for controlled release of the antimicrobial subtilosin for prophylaxis of bacterial vaginosis.

Authors:  Sujata Sundara Rajan; Veronica L Cavera; Xiaoping Zhang; Yashveer Singh; Michael L Chikindas; Patrick J Sinko
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

Review 4.  Treatment of sexually transmitted bacterial diseases in pregnant women.

Authors:  G G Donders
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

5.  Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole.

Authors:  M N Austin; R H Beigi; L A Meyn; S L Hillier
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

6.  Evidence for Gardnerella vaginalis uptake and internalization by squamous vaginal epithelial cells: implications for the pathogenesis of bacterial vaginosis.

Authors:  Christy N Marrs; Susan M Knobel; Wen Qin Zhu; Stephanie D Sweet; Ahsen R Chaudhry; Donald J Alcendor
Journal:  Microbes Infect       Date:  2011-12-24       Impact factor: 2.700

Review 7.  The aetiology of bacterial vaginosis.

Authors:  Y Turovskiy; K Sutyak Noll; M L Chikindas
Journal:  J Appl Microbiol       Date:  2011-03-14       Impact factor: 3.772

8.  A blinded, randomized controlled trial of high-dose vitamin D supplementation to reduce recurrence of bacterial vaginosis.

Authors:  Abigail Norris Turner; Patricia Carr Reese; Karen S Fields; Julie Anderson; Melissa Ervin; John A Davis; Raina N Fichorova; Mysheika Williams Roberts; Mark A Klebanoff; Rebecca D Jackson
Journal:  Am J Obstet Gynecol       Date:  2014-06-17       Impact factor: 8.661

9.  Behavioral predictors of colonization with Lactobacillus crispatus or Lactobacillus jensenii after treatment for bacterial vaginosis: a cohort study.

Authors:  Caroline Mitchell; Lisa E Manhart; Kathy Thomas; Tina Fiedler; David N Fredricks; Jeanne Marrazzo
Journal:  Infect Dis Obstet Gynecol       Date:  2012-05-30

10.  Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses.

Authors:  Per-Göran Larsson; Erik Brandsborg; Urban Forsum; Sonal Pendharkar; Kasper Krogh Andersen; Salmir Nasic; Lennart Hammarström; Harold Marcotte
Journal:  BMC Infect Dis       Date:  2011-08-19       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.